Kymab investigational site 1108 — Orlando, Florida

Kymab investigational site 1108 is a clinical research site located in Orlando, Florida, United States 32806.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Kymab investigational site 1108 has participated in 1 clinical trials.

Therapeutic areas: Squamous Cell Carcinoma of Head and Neck, Non-small Cell Lung Cancer, Hepatocellular Carcinoma.

Sponsors: Kymab Limited.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kymab investigational site 1108?

Kymab investigational site 1108 has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kymab investigational site 1108 conducted?

Kymab investigational site 1108 has 1 clinical trials on record. Their work covers Squamous Cell Carcinoma of Head and Neck, Non-small Cell Lung Cancer, Hepatocellular Carcinoma.

Is Kymab investigational site 1108 accredited by Crixeo Health?

Kymab investigational site 1108 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kymab investigational site 1108?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.